On Thursday, Shares of PDL BioPharma Inc (NASDAQ:PDLI), lost -4.37% to $6.13.
PDL BioPharma Inc, declared that the company has designated Steffen Pietzke, CPA, to the position of controller and chief accounting officer. Mr. Pietzke officially joins the company this week.
“Steffen is an excellent addition to PDL and brings over 14 years of accounting and financial reporting experience to our team,” stated Peter Garcia, vice president and chief financial officer of PDL BioPharma. “Having recognized more than $580 million in revenues in 2014, PDL is happy with the relevant experience that Steffen brings to our team. His experience in auditing both venture capital firms and biopharmaceutical companies with revenues and with complex financial transactions will further strengthen our finance team and support our income generating efforts.”
PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases.
Shares of Alder Biopharmaceuticals Inc (NASDAQ:ALDR), inclined 1.61% to $51.75, during its last trading session.
Alder Biopharmaceuticals Inc, declared the pricing of an underwritten public offering of 4,494,382 shares of its common stock at a price to the public of $44.50 per share. In addition, Alder has granted the underwriters a 30-day option to purchase up to 674,157 additional shares of common stock at the public offering price. The offering is predictable to close on June 30, 2015, subject to customary closing conditions.
Credit Suisse, Leerink Partners and Wells Fargo Securities are acting as joint book-running managers for the offering. Bernstein is acting as co-manager for the offering.
Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia.
Finally, Nielsen NV (NYSE:NLSN), ended its last trade with -0.29% loss, and closed at $44.99.
This week at Nielsen’s annual Consumer 360 Conference, Nielsen CEO Mitch Barns and Daniel Zhang, CEO of China-based e-commerce giant Alibaba, sat down for a video interview to talk about how global companies are leveraging digital and big data-harnessing strategies for commercial gains amid growing fragmentation, technological developments and evolving consumer demand. The video is housed in Nielsen’s corporate storytelling hub, News Center, to view, link to or embed.
Nielsen N.V. operates as an information and measurement company. The company provides media and marketing information, analytics, and manufacturer and retailer expertise about what and where consumers buy, read, watch and listen. Its Buy segment provides data on retail measurement services, such as market share and competitive sales volumes; insights into distribution, pricing, merchandising, and promotion; consumer panel measurement, which offers insight into shopper behavior and customer segmentation; and consumer intelligence and analytical services for decision making in development and marketing cycles.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
